Status:
COMPLETED
Hemodynamic Optimization During Major Urological Surgery
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Hemodynamic Instability
Eligibility:
All Genders
18-75 years
Brief Summary
In this prospective observational study investigators aim to seek for any possible correlation between the venous to arterial carbon dioxide difference (pCO2 gap) at the end of surgery and the percent...
Detailed Description
During major urological surgery (i.e. cistectomy) investigators will use a minimally invasive hemodynamic monitoring system (Flotrac - Vigileo, Edwards ) to guide fluid therapy and vasopressors admini...
Eligibility Criteria
Inclusion
- patients scheduled for major urological surgery
- ASA 1-2-3
Exclusion
- pregnancy
- obesity with a BMI \> 35
- controindications to central venous catheter positioning
- end-stage renal disease
Key Trial Info
Start Date :
October 5 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 28 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03474224
Start Date
October 5 2018
End Date
July 28 2020
Last Update
June 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Andrea Russo
Rome, Italy, 00166